Octreotide Acetate Kit
Product Images NDC 0480-9259

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 0480-9259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure diagram of Octreotide Acetate, showing the molecular arrangement of amino acids and the acetate group with variable x (1.4 to 2.5) indicated.*

FDA Label Image

1 (Image 10)

An illustration of a circular timer or clock showing a 5-minute interval, with the first five minutes shaded. The text "5 min" is displayed prominently inside the circle.*

FDA Label Image

1 (Image 11)

An instructional illustration showing a hand holding a syringe and aligning it with a vial. The image includes a bidirectional arrow indicating a connection or attachment step, likely part of preparing an intramuscular injection kit.*

FDA Label Image

1 (Image 12)

An instructional illustration showing a gloved hand attaching or withdrawing medication from a vial using a syringe, with an arrow indicating downward direction. This image relates to preparation steps for administering Octreotide Acetate kit via intramuscular route.*

FDA Label Image

1 (Image 13)

An instructional illustration showing hands disconnecting a vial or cartridge from a cap or holder, with arrows indicating the direction of removal. This image is part of an Octreotide Acetate intramuscular injection kit by Teva Pharmaceuticals, demonstrating a step in medication preparation.*

FDA Label Image

1 (Image 14)

An instructional illustration showing two hands assembling an injection syringe by attaching the needle part to the syringe body, indicated by arrows guiding the connection steps. This diagram likely relates to preparation of an intramuscular injection kit for Octreotide Acetate.*

FDA Label Image

1 (Image 15)

An instructional illustration showing hands preparing an intramuscular injection using a vial and needle. One hand holds the vial while the other removes the needle cap, indicated by an upward arrow. A close-up inset shows a drop of liquid at the needle tip, demonstrating proper preparation for injection.*

FDA Label Image

1 (Image 16)

An instructional diagram showing injection sites for Octreotide Acetate intramuscular administration. The illustration depicts a hand holding a syringe at a 90-degree angle to the upper outer quadrant of the buttock, highlighting recommended injection sites with arrows.*

FDA Label Image

1 (Image 17)

Instructional diagram showing how to attach a needle to a syringe. The first panel (A) demonstrates removing protective covers from the needle and syringe tip. The second panel (B) shows attaching the needle to the syringe by pushing it onto the tip. An additional image suggests the assembled syringe with needle, including an icon of an ear and sound waves, possibly indicating audible feedback during attachment.*

FDA Label Image

20 mg Carton (Image 18)

Packaging label for Octreotide Acetate for Injectable Suspension, 20 mg, in a kit form intended for gluteal intramuscular use. The label shows Teva Pharmaceuticals as the manufacturer. It includes dosage form, strength, route of administration, storage instructions, inactive ingredients, and detailed usage warnings.*

FDA Label Image

30 mg Carton (Image 19)

Packaging label for Octreotide Acetate for Injectable Suspension, 30 mg, for gluteal intramuscular use. The kit is labeled for prescription use only and is manufactured by Teva Pharmaceuticals, Inc. The label includes dosage form, strength, storage instructions, and directions to protect from light and refrigerate. The NDC number 0480-9262-08 is visible on the carton.*

FDA Label Image

1 (Image 2)

A circular clock illustration showing a 30-minute interval. The left half of the clock is shaded white with a bold "30 min" label, while the right half is shaded gray. This image likely represents a timing instruction or waiting period.*

FDA Label Image

2 (Image 3)

Illustration showing a vial with a flip-off cap partially opened, exposing the vial's stopper. An arrow points upward, indicating the direction to lift the cap. This image relates to preparation or handling of the Octreotide Acetate kit for intramuscular use by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 4)

An instructional illustration showing two hands holding and preparing a small ampule, likely part of a drug administration kit. One hand holds the ampule while the other appears to be twisting or snapping it open, suggesting preparation for intramuscular injection of the medication Octreotide Acetate.*

FDA Label Image

1 (Image 5)

An instructional illustration showing a hand holding a small vial or ampule, likely as part of the Octreotide Acetate intramuscular injection kit by Teva Pharmaceuticals. The image appears to demonstrate preparing or handling the medication for administration.*

FDA Label Image

1 (Image 6)

An instructional illustration showing a hand removing a cap or seal from a vial or vial-like container, positioned above it with a downward arrow indicating direction. Another hand holds the vial steady, and there is an ear icon with sound waves, suggesting listening for a click or other auditory cue during the step.*

FDA Label Image

1 (Image 7)

An illustration depicting a syringe or injection device with a plunger and cap, accompanied by an upward arrow indicating removal or operation direction. The image is a simple line drawing likely related to administration instructions for Octreotide Acetate intramuscular kit.*

FDA Label Image

1 (Image 8)

An instructional illustration showing a hand twisting off the cap of a vial, followed by pressing the vial downwards into a device, demonstrating steps to prepare the Octreotide Acetate intramuscular injection kit for use.*

FDA Label Image

1 (Image 9)

An instructional illustration showing hands preparing a syringe by pressing it down into a vial with an arrow pointing downward, likely demonstrating assembly or medication withdrawal steps for an intramuscular injection kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.